Drinking Water Arsenic Contamination, Skin Lesions, and Malignancies: A Systematic Review of the Global Evidence

Current environmental health reports

Volumn 2, Issue 1, 2015, Pages 52-68

  Karagas, Margaret R ^a,b   Gossai, Anala ^a   Pierce, Brandon ^c   Ahsan, Habibul ^c  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b University of Chicago ^*  (United States)

^c UNIVERSITY OF CHICAGO   (United States)

Author keywords

Arsenic; Arsenic metabolism; Basal cell carcinoma; Drinking water exposure; Inorganic arsenic; Low dose exposure; Organic arsenic; Skin cancer; Skin lesions; Squamous cell carcinoma; Total arsenic

Indexed keywords

ARSENIC; DRINKING WATER;

ADVERSE EFFECTS; ANALYSIS; ARSENIC POISONING; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; CHEMICALLY INDUCED; DOSE RESPONSE; ENVIRONMENTAL EXPOSURE; HEALTH; HUMAN; MALE; SKIN DISEASES; WATER POLLUTION;

ARSENIC; ARSENIC POISONING; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRINKING WATER; ENVIRONMENTAL EXPOSURE; GLOBAL HEALTH; HUMANS; MALE; SKIN DISEASES; WATER POLLUTION, CHEMICAL;

EID: 84960099336     PISSN: None     EISSN: 21965412     Source Type: Journal    
DOI: 10.1007/s40572-014-0040-x     Document Type: Review

References (67)

1. Saha KC. Diagnosis of arsenicosis. J Environ Sci Health B. 2003;38(1):255–72.
2. Haque R, Mazumder DN, Samanta S, Ghosh N, Kalman D, Smith MM, et al. Arsenic in drinking water and skin lesions: dose-response data from West Bengal. India Epidemiol. 2003;14(2):174–82. doi:10.1097/01.ede.0000040361.55051.54.
3. Ghosh P, Banerjee M, De Chaudhuri S, Chowdhury R, Das JK, Mukherjee A, et al. Comparison of health effects between individuals with and without skin lesions in the population exposed to arsenic through drinking water in West Bengal, India. J Expo Sci Environ Epidemiol. 2007;17(3):215–23. doi:10.1038/sj.jes.7500510.
4. Saha K. Review of arsenicosis in west Bengal, India—a clinical perspective. Crit Rev Environ Sci Technol. 2003;33(2):127–63.
5. Saha KC. Diagnosis of arsenicosis. J Environ Sci Health A. 2003;38(1):255–72.
6. Arsenic and Arsenic Compounds. Lyon, France: WHO, International Agency for Research on Cancer. 1987.
7. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Some drinking-water disinfectants and contaminants, including arsenic. IARC monographs on the evaluation of carcinogenic risks to humans/World Health Organization, International Agency for Research on. Cancer. 2004;84:1.
8. International Agency for Research on Cancer Special Report: Policy, A review of Human Carcinogens—Part C: Metals, Arsenic, Dusts, and Fibres. Lyon, France: IARC Press; 2009.
9. Tseng W, Chu HM, How S, Fong J, Lin C, Yeh S. Prevalence of skin cancer in an endemic area of chronic arsenicism in Taiwan. J Natl Cancer Inst. 1968;40(3):453–63.
10. Neubauer O. Arsenical cancer: a review. Br J Cancer. 1947;1(2):192.
11. Yeh S, How S, Lin C. Arsenical cancer of skin: histologic study with special reference to Bowen's disease. Cancer. 1968;21(2):312–39.
12. Neumann E, Schwank R. Multiple malignant and benign epidermal and dermal tumours following arsenic. Acta Derm Venereol. 1960;40:400–9.
13. Beane Freeman LE, Dennis LK, Lynch CF, Thorne PS, Just CL. Toenail arsenic content and cutaneous melanoma in Iowa. Am J Epidemiol. 2004;160(7):679–87. doi:10.1093/aje/kwh267160/7/679.
14. Agusa T, Fujihara J, Takeshita H, Iwata H. Individual Variations in inorganic arsenic metabolism associated with AS3MT genetic polymorphisms. Int J Mol Sci. 2011;12(4):2351–82. doi:10.3390/ijms12042351ijms-12-02351.
15. Pierce BL, Kibriya MG, Tong L, Jasmine F, Argos M, Roy S, et al. Genome-wide association study identifies chromosome 10q24.32 variants associated with arsenic metabolism and toxicity phenotypes in Bangladesh. PLoS Genet. 2012;8(2):e1002522. doi:10.1371/journal.pgen.1002522PGENETICS-D-11-02123.
16. Pierce BL, Tong L, Argos M, Gao J, Farzana J, Roy S, et al. Arsenic metabolism efficiency has a causal role in arsenic toxicity: mendelian randomization and gene-environment interaction. Int J Epidemiol. 2013;42(6):1862–71. doi:10.1093/ije/dyt182. This study demonstrated an interaction between arsenic exposure and 10q24.32 (AS3MT) genotype among Bangladeshi individuals, with exposure showing a stronger association with skin lesion risk among individuals with the low metabolism efficiency genotype.
17. De Chaudhuri S, Ghosh P, Sarma N, Majumdar P, Sau TJ, Basu S, et al. Genetic variants associated with arsenic susceptibility: study of purine nucleoside phosphorylase, arsenic (+3) methyltransferase, and glutathione S-transferase omega genes. Environ Health Perspect. 2008;116(4):501–5. doi:10.1289/ehp.10581.
18. Hernandez A, Marcos R. Genetic variations associated with interindividual sensitivity in the response to arsenic exposure. Pharmacogenomics. 2008;9(8):1113–32. doi:10.2217/14622416.9.8.1113.
19. World Health Organization. Arsenic in drinking-water: background document for development of WHO guidelines for drinking-water quality. 2003.
20. Tsai S-M, Wang T-N, Ko Y-C. Mortality for certain diseases in areas with high levels of arsenic in drinking water. Arch Environ Health. 1999;54(3):186–93.
21. Chen C-J, Chuang Y-C, Lin T-M, Wu H-Y. Malignant neoplasms among residents of a blackfoot disease-endemic area in Taiwan: high-arsenic artesian well water and cancers. Cancer Res. 1985;45(11 Part 2):5895–9.
22. Wu M-M, Kuo T-L, Hwang Y-H, Chen C-J. Dose-response relation between arsenic concentration in well water and mortality from cancers and vascular diseases. Am J Epidemiol. 1989;130(6):1123–32.
23. Tseng W-P. Effects and dose-response relationships of skin cancer and blackfoot disease with arsenic. Environ Health Perspect. 1977;19:109.
24. Tseng W-P. Blackfoot disease in Taiwan: a 30-year follow-up study. Angiology. 1989;40(6):547–58.
25. Zaldívar R. Arsenic contamination of drinking water and foodstuffs causing endemic chronic poisoning. Beitr Pathol. 1974;151(4):384–400.
26. Mitra AK, Bose BK, Kabir H, Das BK, Hussain M. Arsenic-related health problems among hospital patients in southern Bangladesh. J Health Pop Nutr. 2002:198–204.
27. Francesconi KA, Tanggaar R, McKenzie CJ, Goessler W. Arsenic metabolites in human urine after ingestion of an arsenosugar. Clin Chem. 2002;48(1):92–101.
28. Karagas MR, Tosteson TD, Blum J, Klaue B, Weiss JE, Stannard V, et al. Measurement of low levels of arsenic exposure: a comparison of water and toenail concentrations. Am J Epidemiol. 2000;152(1):84–90.
29. Cuzick J, Evans S, Gillman M, Price Evans DA. Medicinal arsenic and internal malignancies. Br J Cancer. 1982;45(6):904–11.
30. Scientific Opinion on Arsenic in Food. European Food Safety Authority: panel on Contaminants in the Food Chain (CONTAM). 2009;10:1351.
31. Critical Aspects of EPA's IRIS Assessment of Inorganic Arsenic: Interim Report. The National Academies Press; 2014.
32. Argos M, Kalra T, Pierce BL, Chen Y, Parvez F, Islam T, et al. A prospective study of arsenic exposure from drinking water and incidence of skin lesions in Bangladesh. Am J Epidemiol. 2011;174(2):185–94. This study provides a clear dose-response relationship between well water arsenic and skin lesion incidence in a large sample of the Bangladeshi population.
33. Kile ML, Hoffman E, Rodrigues EG, Breton CV, Quamruzzaman Q, Rahman M, et al. A pathway-based analysis of urinary arsenic metabolites and skin lesions. Am J Epidemiol. 2011;173(7):778–86. doi:10.1093/aje/kwq427. This study uses pathway analysis in a case-control study to associate the risk of skin lesions with all urinary arsenic species, simultaneously.
34. Lindberg A-L, Sohel N, Rahman M, Persson LA, Vahter M. Impact of smoking and chewing tobacco on arsenic-induced skin lesions. Environ Health Perspect. 2010;118(4):533–8.
35. Lindberg A-L, Rahman M, Persson L-Å, Vahter M. The risk of arsenic induced skin lesions in Bangladeshi men and women is affected by arsenic metabolism and the age at first exposure. Toxicol Appl Pharmacol. 2008;230(1):9–16.
36. McDonald C, Hoque R, Huda N, Cherry N. Risk of arsenic-related skin lesions in Bangladeshi villages at relatively low exposure: a report from Gonoshasthaya Kendra. Bull World Health Organ. 2007;85(9):668–73.
37. Ahsan H, Chen Y, Kibriya MG, Slavkovich V, Parvez F, Jasmine F, et al. Arsenic metabolism, genetic susceptibility, and risk of premalignant skin lesions in Bangladesh. Cancer Epidemiol Biomark Prev. 2007;16(6):1270–8.
38. Rahman M, Vahter M, Sohel N, Yunus M, Wahed MA, Streatfield PK, et al. Arsenic exposure and age-and sex-specific risk for skin lesions: a population-based case-referent study in Bangladesh. Environ Health Perspect. 2006:1847–52.
39. Hall M, Chen Y, Ahsan H, Slavkovich V, Van Geen A, Parvez F, et al. Blood arsenic as a biomarker of arsenic exposure: results from a prospective study. Toxicology. 2006;225(2):225–33.
40. Tondel M, Rahman M, Magnuson A, Chowdhury IA, Faruquee MH, Ahmad SA. The relationship of arsenic levels in drinking water and the prevalence rate of skin lesions in Bangladesh. Environ Health Perspect. 1999;107(9):727–9.
41. Ahsan H, Chen Y, Parvez F, Zablotska L, Argos M, Hussain I, et al. Arsenic exposure from drinking water and risk of premalignant skin lesions in Bangladesh: baseline results from the Health Effects of Arsenic Longitudinal Study. Am J Epidemiol. 2006;163(12):1138–48.
42. Haque R, Mazumder DG, Samanta S, Ghosh N, Kalman D, Smith MM, et al. Arsenic in drinking water and skin lesions: dose-response data from West Bengal, India. Epidemiology. 2003;14(2):174–82.
43. Mazumder DNG, Haque R, Ghosh N, De Binay K, Santra A, Chakraborty D, et al. Arsenic levels in drinking water and the prevalence of skin lesions in West Bengal, India. Intl J Epidemiol. 1998;27(5):871–7.
44. Fatmi Z, Azam I, Ahmed F, Kazi A, Gill AB, Kadir MM, et al. Health burden of skin lesions at low arsenic exposure through groundwater in Pakistan. Is river the source? Environ Res. 2009;109(5):575–81.
45. Fatmi Z, Abbasi IN, Ahmed M, Kazi A, Kayama F. Burden of skin lesions of arsenicosis at higher exposure through groundwater of taluka Gambat district Khairpur, Pakistan: a cross-sectional survey. Environ Geochem Health. 2013;35(3):341–6.
46. Wilhelm M, Wittsiepe J, Schrey P, Hilbig A, Kersting M. Consumption of homegrown products does not increase dietary intake of arsenic, cadmium, lead, and mercury by young children living in an industrialized area of Germany. Sci Total Environ. 2005;343(1):61–70.
47. Chen Y, Graziano JH, Parvez F, Hussain I, Momotaj H, van Geen A, et al. Modification of risk of arsenic-induced skin lesions by sunlight exposure, smoking, and occupational exposures in Bangladesh. Epidemiology. 2006;17(4):459–67.
48. Pierce BL, Argos M, Chen Y, Melkonian S, Parvez F, Islam T, et al. Arsenic exposure, dietary patterns, and skin lesion risk in Bangladesh: a prospective study. Am J Epidemiol. 2011;173(3):345–54.
49. Zablotska LB, Chen Y, Graziano JH, Parvez F, van Geen A, Howe GR, et al. Protective effects of B vitamins and antioxidants on the risk of arsenic-related skin lesions in Bangladesh. Environ Health Perspect. 2008;116:1056–62. doi:10.1289/ehp.10707.
50. Xia Y, Wade TJ, Wu K, Li Y, Ning Z, Le XC, et al. Well water arsenic exposure, arsenic induced skin-lesions and self-reported morbidity in Inner Mongolia. Intl J Environ Res Pub Health. 2009;6(3):1010–25.
51. Guo X, Fujino Y, Ye X, Liu J, Yoshimura T. Association between multi-level inorganic arsenic exposure from drinking water and skin lesions in China. Intl J Environ Res Pub Health. 2006;3(3):262–7.
52. Karagas MR, Stukel TA, Morris JS, Tosteson TD, Weiss JE, Spencer SK, et al. Skin cancer risk in relation to toenail arsenic concentrations in a US population-based case-control study. Am J Epidemiol. 2001;153(6):559–65.
53. Karagas MR, Stukel TA, Tosteson TD. Assessment of cancer risk and environmental levels of arsenic in New Hampshire. Intl J Hyg Environ Health. 2002;205(1):85–94.
54. Hsueh Y, Cheng G, Wu M, Yu H, Kuo T, Chen C. Multiple risk factors associated with arsenic-induced skin cancer: effects of chronic liver disease and malnutritional status. Br J Cancer. 1995;71(1):109–14.
55. Hsueh Y-M, Chiou H-Y, Huang Y-L, Wu W-L, Huang C-C, Yang M-H, et al. Serum beta-carotene level, arsenic methylation capability, and incidence of skin cancer. Cancer Epidemiol Biomark Prev. 1997;6(8):589–96.
56. Baastrup R, Sorensen M, Balstrom T, Frederiksen K, Larsen CL, Tjonneland A, et al. Arsenic in drinking-water and risk for cancer in Denmark. Environ Health Perspect. 2008;116(2):231–7. doi:10.1289/ehp.10623.
57. Ranft U, Miskovic P, Pesch B, Jakubis P, Fabianova E, Keegan T, et al. Association between arsenic exposure from a coal-burning power plant and urinary arsenic concentrations in Prievidza District, Slovakia. Environ Health Perspect. 2003;111(7):889–94.
58. Pesch B, Ranft U, Jakubis P, Nieuwenhuijsen MJ, Hergemöller A, Unfried K, et al. Environmental arsenic exposure from a coal-burning power plant as a potential risk factor for nonmelanoma skin carcinoma: results from a case-control study in the district of Prievidza, Slovakia. Am J Epidemiol. 2002;155(9):798–809.
59. Leonardi G, Vahter M, Clemens F, Goessler W, Gurzau E, Hemminki K, et al. Inorganic arsenic and basal cell carcinoma in areas of Hungary, Romania, and Slovakia: a case-control study. Environ Health Perspect. 2012;120(5):721–6. doi:10.1289/ehp.1103534.
60. Chen Y-C, Guo Y-LL, Su H-JJ, Hsueh Y-M, Smith TJ, Ryan LM, et al. Arsenic methylation and skin cancer risk in southwestern Taiwan. J Occup Environ Med. 2003;45(3):241–8.
61. Gilbert-Diamond D, Li Z, Perry AE, Spencer SK, Gandolfi AJ, Karagas MR. A population-based case–control study of urinary arsenic species and squamous cell carcinoma in New Hampshire, USA. Environ Health Perspect. 2013;121(10):1154.
62. Rosales-Castillo JA, Acosta-Saavedra LC, Torres R, Ochoa-Fierro J, Borja-Aburto VH, Lopez-Carrillo L, et al. Arsenic exposure and human papillomavirus response in non-melanoma skin cancer Mexican patients: a pilot study. Intl Arch Occup Environ Health. 2004;77(6):418–23. doi:10.1007/s00420-004-0527-0.
63. Farzan SF, Waterboer T, Gui J, Nelson HH, Li Z, Michael KM, et al. Cutaneous alpha, beta and gamma human papillomaviruses in relation to squamous cell carcinoma of the skin: a population‐based study. Intl J Cancer. 2013;133(7):1713–20.
64. Valenzuela OL, Borja-Aburto VH, Garcia-Vargas GG, Cruz-Gonzalez MB, Garcia-Montalvo EA, Calderon-Aranda ES, et al. Urinary trivalent methylated arsenic species in a population chronically exposed to inorganic arsenic. Environ Health Perspect. 2005:250–4.
65. Gao J, Yu J, Yang L. Urinary arsenic metabolites of subjects exposed to elevated arsenic present in coal in Shaanxi Province, China. Int J Environ Res Publ Health. 2011;8(6):1991–2008. doi:10.3390/ijerph8061991ijerph-08-01991.
66. Yu RC, Hsu K-H, Chen C-J, Froines JR. Arsenic methylation capacity and skin cancer. Cancer Epidemiol Biomark Prev. 2000;9(11):1259–62.
67. Zhang Q, Wang D, Zheng Q, Zheng Y, Wang H, Xu Y, et al. Joint effects of urinary arsenic methylation capacity with potential modifiers on arsenicosis: a cross-sectional study from an endemic arsenism area in Huhhot Basin, northern China. Environ Res. 2014;132:281–9.